Intelligo

Private limited company · Bergen

PCG PHARMACIES AS

ActiveRetail sale of pharmaceutical products (47.730)

Founded
22 Mar 2018
Employees
12
Chief executive
Ingelill Kleivnes
Business address
Drotningsvikveien 132, 5179 Godvik

The life line 2018–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 27.3m.

  1. Managing director took office§ 07
  2. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

PCG PHARMACIES AS is a private limited company in Bergen, founded in 2018, in the industry retail sale of pharmaceutical products. The chief executive is Ingelill Kleivnes, and the chair of the board is Ingelill Kleivnes. In 2025 the company had NOK 27.3m in operating revenue and a net profit of NOK 425k. The largest owner is PESCA CONSULTING GROUP AS with 100.0%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 12 Nov 2026

  • Number of employees 13 → 12
  • Endring av revisor
  • Annual accounts filed 2024 → 2025
  • Godkjent årsregnskap

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

2 points

  • NoteChanged auditor 29 Sep 2026
  • OKEquity ratio 20.4%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 27.3m in 2025

Revenue

NOK 27.3m

+3.5% from 2024

20232025

Operating profit

NOK 569k

−41.7% from 2024

20232025

Net profit

NOK 425k

−42.9% from 2024

20232025

Equity

NOK 1.1m

+12.6% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 20%
  • Depreciation 0%
  • Other operating costs 5%
  • Not specified in the source 73%
  • Left as operating result 2%

Of the net profit for 2025, NOK 120k stayed in the company. The rest, NOK 305k, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 20.4%

RevenueNOK 27.3m Operating margin2.1% Equity ratio20.4% Revenue growth+3.5%
  • PCG PHARMACIES AS, 2025
  • Industry median, assumed: NOK 19.4m · 2.5% · 14.5% · +6.6%

Equity NOK 1.1m20% of the assets (NOK 5.3m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 223 companies in 47.730 Retail sale of pharmaceutical products, not stated by the source.

Finances

§ 06 Accounts

8 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue27,30526,38524,537
Operating profit5699771,008
Profit before tax546956998
Net profit425745727
Total assets5,2694,9976,982
Equity1,073953459
Liabilities4,1964,0446,522

Source: the Register of Company Accounts, read 15 Nov 2026 · All 8 years →

Management and ownership

§ 07 Officers

5 officers now

The board: 2 members

Source: the Brønnøysund Register Centre, read 30 Sep 2026 · All 5 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Styrets leder alene.

May sign for the company:

Styrets leder alene.

Procuration: none registered.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 3 Oct 2026

Management and ownership

§ 09 Owners

1 shareholder · largest 100.0%

OwnerShare
PESCA CONSULTING GROUP AS
100.0%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

16 connections

  • Person
  • Company

2 people link PCG PHARMACIES AS to 6 other companies: Arne Aarhus 6 and Ingelill Kleivnes 5.

Source: the Brønnøysund Register Centre, read 30 Sep 2026 · Explore the network →

Events and registers

§ 13 Events

18 since 2018

Events per year

20182026

  • Notices13
  • Register changes5

Since 2018: 13 announcements and 5 register changes. Most happened in 2018 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 18 events →

Events and registers

§ 14 Notices

13, latest 29 Sep 2026

  • Revisor
  • Godkjente årsregnskap
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 13 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 2 Jun 2018
  • VATRegistered
  • The Register of Business EnterprisesRegistered 2 Jun 2018
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Eierskap og drift av apotek, samt salg av farmasøytiske tjenester og alt som hører inn under dette, samt deltakelse i andre foretak med farmasirelatert virksomhet.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 47.730

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of PCG PHARMACIES AS?
    Ingelill Kleivnes, since 2018. § 07
  • Who owns PCG PHARMACIES AS?
    1 shareholder. It is PESCA CONSULTING GROUP AS with 100.0%. § 09
  • What was the revenue in 2025?
    NOK 27.3m in the company. § 06
  • Who can sign for PCG PHARMACIES AS?
    Styrets leder alene. § 08
  • Who is the auditor?
    HOVDEN & VATNE STATSAUTORISERTE REVISORAR AS, from 29 Sep 2026. § 07
  • Where is PCG PHARMACIES AS based?
    Drotningsvikveien 132, 5179 Godvik.
  • When was PCG PHARMACIES AS founded?
    22 Mar 2018, registered in the Register of Business Enterprises 2 Jun 2018. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose